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the possible expression of an IL-12 receptor (IL-12R) by
DC. The results indicate that DC express an IL-12R and
that IL-12 signaling in these cells may involve early
events that differ from those operating in T lymphocytes,
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Results
Summary
Binding of IL-12 to DC
We analyzed the expression of an IL-12 receptor by Transfer of DC exposed sequentially to IL-12 and a tu-
fresh dendritic cells (DC) and a DC line. Using RT- mor peptide, P815AB, confers CD81 cell-mediated reac-
PCR, RNAse protection, and electrophoretic mobility tivity on prospective recipients of an intrafootpad chal-
shift assay analysis, we found that DC possess an lenge with the tumor peptide (Bianchi et al., 1996;
IL-12 receptor with b1 subunit (downstream box 1)- Grohmann et al., 1997), which is accompanied by in-
related differences from that on T cells. IL-12 signaling creased resistance to challenge with tumor cells ex-
through this receptor involved members of the NF-kB pressing the otherwise poorly immunogenic rejection
but not STAT family. The unique properties of the IL- antigen P815AB (Grohmann et al., 1998). To investigate
12 receptor on DC, characterized by a single class of possible direct effects of IL-12 on DC, we first used
binding sites with a Kd of about 325 pM, may underlie flow cytometry for detection of IL-12 binding to highly
rather unique effects, such as IFNg-independent aug- purified DC cultures (as assessed by the presence of
mentation of class II antigen expression and priming specific markers; Figure 1). Using double staining in a
for LPS-induced production of IL-12. sandwich procedure with IL-12 and fluoresceinated IL-
12-specific C17.8 MAb or control rat IgG, only thecombi-
Introduction nation of externally added IL-12 and the IL-12-specific
antibody resulted in a high proportion of cells (58%)
IL-12 serves a major role in the early inflammatory re- staining positively for bound IL-12 and the specific DC
sponse to infections (Trinchieri, 1995). In addition, IL- marker CD11c (data not shown). We thus performed
12 produced by APC is critically involved in the genera- kinetic and equilibrium binding analysis of radiolabeled
tion of T helper type 1 (Th1) cells (Hsieh et al., 1993) and IL-12 binding to DC. The kinetics of association of [125I]IL-
is required for optimal differentiation of CTL (Gately et 12 was examined comparatively in DC and Con A±acti-
al., 1992). These activities likely mediate or contribute vated lymphoblasts. The binding of labeled IL-12 to both
to the antitumor effects observed in mice bearing a vari- types of cells at room temperature appeared to be rapid,
ety of malignancies and treated locally or systemically reaching equilibrium between 30 and 60 min for DC and
with IL-12 (Brunda etal., 1995; Zitvogel et al.,1995). Most between 60 and 120 min for Con A blasts. By plotting
of these effects are thought to involve direct actions on 2ln[12B/Bmax] versus time (Coligan et al., 1994), where
T (Seder et al., 1993) and NK cells (Kobayashi et al., B represents bound cpm and Bmax represents the maxi-
1989). Binding of IL-12 to human and murine B lympho- mum bound cpm achieved at equilibrium, the observed
cytes has recently been reported, suggesting that IL-12 association rate constant for DC (slope of the resulting
can directly affect humoral immunity (Vogel et al., 1996), straight-line curve, indicating a single type of receptor)
besides acting as an initiator of cell-mediated reactivity was 0.045 min21 (Figure 2A). Consistent with the occur-
(Scott, 1993). rence of two classes of IL-12 receptors on Con A±acti-
DC are the most potent cellular initiators of the im- vated splenocytes (i.e., high- and low-affinity receptors)
mune response and, inparticular, are responsible for the (Presky et al., 1996; Wu et al., 1997), two distinct curves
induction of primary antigen-specific immune reactions and consequently, association rate constants were de-
(Steinman and Cohn, 1973; Steinman, 1991). In keeping tected in these cells, 0.055 min21 and 0.008 min21 (data
with this notion is their ability to secrete IL-12 and to not shown). Binding assays were then performed with
direct the development of Th1 cells from naive CD41 T different concentrations of radioligand using DC and
cells (Macatonia et al., 1995). Based on our previous Con A blasts,and Scatchard plots of the specific binding
finding that recombinant IL-12 will prime purified DC data were analyzed by means of the LIGAND program,
cultures pulsed with a tumor peptide in vitro for effective with a single (DC) or double (Con A blasts) site model.
sensitization in vivo (Grohmann et al., 1995a, 1997, 1998; As expected, Con A blasts displayed both high (Kd 5
Bianchi et al., 1996), the present study has investigated 14.4 6 5.3 pM with 103 6 25 sites/cell)- and low (Kd 5
2.4 6 0.4 nM with 1556 6 740 sites/cell)-affinity IL-12
binding sites (data not shown), whereas DC (Figure 2B)³To whom correspondence should be addressed (e-mail: pccplo
@tin.it). expressed only high-affinity IL-12 binding sites (Kd 5
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Figure 1. Cytofluorimetric Analysis of Puri-
fied DC Stained with a Set of MAbs Against
Various Determinants Specific for DCor Tand
B Lymphocytes
Numbers within boxes indicate percentage
of positive cells above background values
(closed histograms).
325 6 61 pM with 155 6 9 sites/cell, mean 6 SEM of and CB1 cells, b2-specific transcripts were clearly ex-
pressed but no evidence was obtained for the presencethree experiments). In competitive binding of labeled IL-
12 to DC by unlabeled IL-12, we found a KI value of of b1-specific messages (Figure 3A). These results were
confirmed by the more stringent technique of RNase240 6 42 pM with 130 6 12 sites/cell (data not shown).
In experiments not reported here, we also found that protection analysis, although the data for b1 transcript
expression in DC were less clear (Figure 3B). This raisedthe presence of 100 nM concentrations of murine IL-1a,
GM-CSF, IFNg, and TNFa did not block binding of 500 the possibility that our failure to detect b1 transcripts
might be due to the use of inappropriate primers. WepM labeled IL-12, thus demonstrating specificity of the
IL-12 binding. have thus begun to systematically examine a series of
different b1 primers comprising regions encoding differ-
ent domains of the b1 chain. We consistently found PCRAnalysis of IL-12R Subunit mRNA Expression
products of the expected sizeusing b1 primers spanningby DC and a DC Line
the extracellular, transmembrane, and cytoplasmic re-IL-12 receptors, primarily expressed on activated T and
gions up to at least nucleotide 1865, belonging in theNK cells, are gp130-like cytokine receptor superfamily
box 1 motif (Stahl and Yancopoulos, 1993). All of thesemembers. Having the general makeup of b type cyto-
amplicons were sequenced and proved to be identicalkine receptor subunits, they are designated as IL-12Rb1
to the corresponding published sequences (Chua et al.,and IL-12Rb2. Coexpression of IL-12Rb1 and IL-12Rb2
1995). As an example, Figure 3A reports PCR data usingleads to the formation of high-affinity IL-12-binding sites
a b1 sense primer consisting of nucleotides 239±259 and(Presky et al., 1996). Freshly isolated DC and the pre-
a b1 antisense primer comprising nucleotides 788±807.viously characterized DC line, CB1 (Paglia et al., 1993),
were examined for the expression of the IL-12Rb1 and
b2 chains by RT-PCR and RNase protection analysis. IL-12 Does Not Activate Stat3 and Stat4
for DNA Binding in DCIn a first set of experiments, and using previously de-
scribed b1 primers (Chua et al., 1995) (sense, nucleo- The IL-12Rb2 subunit is a signal-transducing compo-
nent of the IL-12R (Presky et al., 1996), and IL-12 signal-tides 1073±1092; antisense, 2220±2239), we compara-
tively analyzed the expression of IL-12Rb1 and b2 ing in Th1 cells involves tyrosine phosphorylation of
signal transducers and activators of transcription (Stat)3messages in Con A lymphoblasts, fresh DC, the CB1
line, and the A20 B lymphoma line. The A20 cells were and Stat4 (Jacobson et al., 1995; Szabo et al., 1997). To
examine IL-12 signaling in DC, we wondered whether theused as a negative control because preliminary experi-
ments had shown failure of IL-12 to increase the APC cytokine might induce STAT factors capable of binding
DNA (Figure4). The FcgRI probe, from the IFNg responseability of A20 cells in in vitro and in vivo assays. As
expected (Chua et al., 1995; Presky et al., 1996), the region of the high-affinity FcgR promoter (Jacobson et
al., 1995), has distinct binding specificity for variousCon A lymphoblasts expressed both b1 and b2 tran-
scripts, but neither was expressed in A20 cells. In DC STAT family members and can be used as a probe in
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Figure 2. Kinetics and Equilibrium Binding Analysis of Radiolabeled
IL-12 Binding to DC
(A) Kinetics of association of 500 pM [125I]IL-12 at room temperature
in the presence or absence of 50 nM unlabeled IL-12. The curve
represents specific binding of labeled IL-12, where B is bound cpm
and Bmax is the maximum bound cpm at equilibrium.
(B) Scatchard analysis of [125I]IL-12 binding. Cells were incubated for
2 hr at room temperature with various concentrations of radioligand.
Results are expressed as specific binding data that were analyzed
by the method of Scatchard. One experiment representative of three
is shown for each assay.
Figure 3. IL-12R Gene Transcription in DC
(A) RT-PCR analysis of IL-12Rb1 and IL-12Rb2 mRNA expressionelectrophoretic mobility shift assay (EMSA) analysis.The
in Con A±activated splenic lymphoblasts (SC/Con A), DC, CB1 cells,assay was performed on fresh DC and CB1 cells using
and A20 cells. cDNA prepared from each cell population was PCR-
Con A blasts and IFNg-treated DC as positive controls. amplified using b1 primer pairs that bridge different areas in the
Nuclear extracts of IL-12-treated or untreated cells were mRNA. PCR products were normalized to b-actin. Symbols: S,
incubated with the labeled FcgRI probe prior to separa- marker track; N, no DNA added to the amplification mix during PCR.
Data are representative of eight separate experiments in which DCtion by native polyacrylamide gel. The results showed
(96%±98% pure) were purified by either technique described in Ex-that nuclear complexes binding to FcgRI were clearly
perimental Procedures.expressed by Con A blasts treated with IL-12 and IFNg-
(B) RNase protection analysis of the IL-12Rb1 and IL-12Rb2 tran-
treated DC but not by DC and CB1 cells exposed to IL- scripts in the same cell populations. b-actin RNA was used as a
12. In accordance with previous evidence that IL-12 loading control. One experiment representative of three.
induces Stat4 homodimers and Stat3/Stat4 heterodi-
mers in T cells (Jacobson et al., 1995), we found that
the addition of anti-Stat antisera removed the majority play a crucial role in the activation of cytokine promoters
(Prieschl et al., 1996). Using EMSA analysis, we investi-(anti-Stat3) or the totality (anti-Stat4) of the nuclear com-
plexes binding to FcgRI. Although the FcgRI probe may gated the possible nuclear uptake of NF-kB complexes
in DC treated with IL-12. Nuclear extracts were obtainedhave different relative affinities for the various members
of the STAT family, these results implied that the possi- from normal spleen cells, Con A splenocytes, DC, and
CB1 cells, treated or not with IL-12. A combination ofble mechanisms of IL-12 signaling in DC would, at least
in part, be different from those in T cells. PMA and ionomycin, known to activate NF-kB in DC
(Prieschl et al., 1996), was also included in the assay as
a positive control. Two different probes were used, oneIL-12 Activates NF-kB for DNA Binding in DC
NF-kB is a ubiquitous transcription factor that is in- from authentic NF-kB sites from the mu heavy-chain
enhancer (Baeuerle and Henkel, 1994) and a secondvolved in the induction of several proinflammatory cyto-
kines, including IL-12 (Baeuerle and Henkel, 1994). One probe (m12-27) that was derived from the IL-12 p40
promoter and contains an NF-kB half-site (Murphy etof the currently known NF-kB family members, RelB,
has a crucial role in the development and differentiation al., 1995). Figure 5 shows that using the NF-kB probe
(from authentic NF-kB sites), both spleen cells and freshof DC (Burkly et al., 1995; Pettit et al., 1997). Recent
evidence suggests that induction of the TNFa promoter DC displayed activation of NF-kB, presumably because
the factor is easily activated upon physical manipula-in a murine dendritic cell line is controlled by the NF-
kB proteins p50 (NF-kB1) and p65 (RelA) (Prieschl et al., tions of cell cultures (Baeuerle and Henkel, 1994). Nu-
clear uptake of NF-kB complexes after IL-12 treatment1996). It has been suggested that in DC, NF-kB factors
Immunity
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p50 and RelB are Major Transcription Factors
Activated by IL-12 in DC
We also used antisera to various NF-kB family members
to analyze the constituents of the IL-12-induced EMSA
complexes binding to authentic NF-kB sites (Figure 6).
Nuclear extracts were obtained from IL-12-treated DC
to be used in EMSA analysis with the NF-kB probe.
Antisera were used to p50, p65 (RelA), RelB, or c-Rel in
combination with nuclear extracts and the NF-kB probe.
The p50 antiserum, but not normal rabbit serum, caused
most of the band to shift significantly, whereas no such
effect was observed with anti-p65 and anti-c-Rel anti-
sera or with an irrelevant antibody to Stat4. Remarkably,
the use of the anti-RelB reagent, but not control serum,
greatly inhibited complex formation with the NF-kB
probe (Figure 6A). Therefore, the p50 and RelB compo-Figure 4. Failure of IL-12 to Induce Nuclear Complexes Containing
nents of theNF-kB family appear to interact with authen-Stat3 and Stat4 in DC
tic NF-kB sites. Analogous results (not reported inFigureNuclear extracts of Con A spleen cells, DC, and CB1 cells were
6A) were obtained when the m12-27 probe was used inprepared after IL-12 treatment. EMSA was performed with the FcgRI
the place of NF-kB. Nuclear translocation of p50 andprobe and antisera to Stat3 and Stat4 or normal rabbit serum (NRS).
The control lane was loaded with probe but no nuclear extract. Free RelB could also be demonstrated directly by immunoflu-
probe is not shown. One of three experiments with the same results. orescence. Figures 6B and 6C report immunostaining
of CB1 cells reacted with anti-p50 antibody, clearly dem-
onstrating translocation of p50 from the cytoplasm towas not modified in normal spleen cellsand Con A blasts
the nucleus after cell treatment with IL-12. Analogousbut was strongly induced (CB1) or enhanced (DC) in the
results were obtained in studying nuclear translocationother cell types to an extent similar to that induced by
of RelB (data not shown).the combination of PMA and ionomycin. In both CB1
and DC, the presence of specific competitors removed
the majority (m12-27) or the totality (NF-kB) of the nu- Increased Class II Molecule Expression
after Exposure of DC to IL-12clear complexes binding to NF-kB. In contrast, an oligo-
nucleotide probe specific for a distinct transcription fac- Because our previous experiments with peptide-pulsed
DC had suggested improved presentation of class II-tor of the STAT family (FcgRI) failed to inhibit complex
formation. Similar results were obtained using probe restricted epitopes of P815AB after sequential exposure
of DC to IL-12 and peptide (Grohmann et al., 1997, 1998),m12-27, although neither spleen cells in the absence
of Con A activation nor fresh DC displayed complex we became interested in analyzing class II antigen ex-
pression and expression of costimulatory molecules information in the absence of IL-12. Because the addition
of cold NF-kB removed complex formation with m12- fresh DC treated with IL-12. We performed cytofluori-
metric analysis of IL-12-exposed cells reacted with anti-27, these results confirmed the previous finding that
m12-27 interacts with selected members of the NF-kB bodies to I-Ad class II molecules (which are known to
bind P815AB epitopes [Grohmann et al., 1997, 1998]),family (Murphy et al., 1995).
Figure 5. Ability of IL-12 to Induce Nuclear
Uptake of NF-kB Complexes in DC
Nuclear extracts of spleen cells (SC), Con A
blasts (SC/Con A), CB1 cells, and DC were
obtained after treatment with either IL-12 or
a combination of PMA and ionomycin. EMSA
was performed with the NF-kB probe or the
m12-27 probe. In assaying CB1 cells and DC,
competitor probes were also used (indi-
cated). The control lane was loaded with
probe but no nuclear extract. Free probe is
not shown. Additional controls (not reported
in the figure) included DC stimulation with
LPS in the absence of IL-12, and no effects
were observed with LPS concentrations up
to 1 mg/ml. One of four experiments with anal-
ogous results.
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Figure 7. IL-12 Production by IL-12-Treated CB1 Cells
CB1 cells were exposed overnight to IL-12 or IFNg followed by
extensive washing and LPS stimulation. At 1 and 24 hr of LPS stimu-
lation, supernatants were assayed for IL-12 p70 contents by ELISA.
The 1 hr IL-12 titers were below the detection limit of the assay.
One of three experiments.
of the IL-12 p40 gene (Ma et al., 1996). Because in our
experiments exposure of DC to IL-12 enhanced nuclear
uptake of NF-kB complexes binding to a p40 promoter
NF-kB half-site,we investigated the possible production
of IL-12 by DC exposed to a combination of IL-12 plus
LPS or IFNg plus LPS. We measured p70 production
by ELISA in culture supernatants of CB1 cells treated
overnight with IFNg or IL-12 (Figure 7). Cells were exten-Figure 6. p50 and RelB are Major Transcription Factors Activated
by IL-12 in DC and the DC Line sively washed and then incubated in fresh medium with
(A) Nuclear extracts from IL-12-treated DC were incubated with or without LPS. Culture supernatants were harvested at
control antisera or antibody against NF-kB family members (p50, 1 and 24 hr. No IL-12 was found in any group at 1 hr,
p65, RelB, or c-Rel). The control antibodies consisted of normal whereas considerable amounts of the cytokine were
rabbit serum (NRS), normal goat serum (NGS), or irrelevant anti-
found at 24 hr in CB1 cells exposed to the combinationStat4 antibody. NF-kB was used as probe. Free probe is not shown.
of IL-12 and LPS. Lack of IL-12 detection at 1 hr clearlyOne of three experiments with the same results. (B) and (C) Effect
indicated that the p70 measured at 24 hr was not derivedof IL-12 on the translocation of NF-kB p50 from the cytoplasm to
the nucleus. Untreated (B) and IL-12-exposed (C) CB1 cells were from externally added IL-12, bound and/or internalized
immunostained with anti-p50 antibody and visualized with rhoda- in CB1 cells. Of interest, significant production of p70
mine-conjugated goat anti-rabbit IgG antibody. was also detected by treatment with IL-12 alone or, to
a lesser extent, with a combination of IFNg and LPS.
B7-1, or B7-2. In several independent experiments, we
consistently observed a reproducible increase in mean Discussion
fluorescence units for I-Ad expression. In contrast, no
reproducible effects were afforded by IL-12 on B7-1 or Our data demonstrate that highly purified murine DC
and a DC line can directly bind IL-12, thus providing theB7-2 expression (data not shown). Although the high
baseline expression of I-Ad molecules on DC (Figure first evidence that IL-12 may act directly on professional
APC that are regarded as the most potent initiators of1) would impede full appreciation of IL-12 effects in
individual experiments, the mean change in linear fluo- the immune response and are responsible for the in-
duction of primary antigen-specific immune reactionsrescence units in eight different experiments was 209 6
102 (mean 6 SD,p 5 0.001)after exposureof .96%pure (Steinman and Cohn, 1973; Steinman, 1991). Using flow
cytometric analysis, we found that a great proportion ofDC to IL-12. When IFNg concentration was measured in
DC culture supernatants at the end of the 18 hr incuba- purified splenic DC expressing very high levels of sur-
face markers typical of late DC such as class II (99%)tion with IL-12, we found that IFNg levels were always
below the detection limit of the assay (i.e., 20 pg/ml). In and B7-2 (97%) (Banchereu and Steinman, 1998) (Figure
1) constitutively express a receptor for IL-12. The addi-addition, no IFNg transcripts were revealed by RT-PCR
following exposure of DC to IL-12 (data not shown). tion of anti-IL-12 alone to DC ablated the detection of
IL-12 binding (data not shown), thus excluding that theThese results suggest that a biologically relevant effect
of IL-12 on DC might be increased class II antigen ex- positive staining was due to the occurrence of DC-
derived IL-12. Experiments of receptor affinity and con-pression independent of the presence of IFNg.
centration dependence, competition, and ligand speci-
ficity with labeled IL-12 in kinetic and equilibrium bindingInduction of Endogenous IL-12 Production
in DC by IL-12 and LPS analysis revealed that the binding of [125I]IL-12 to DC
was saturable and specific, because the binding of ra-In monocytic cells, IFNg enhances IL-12 production
mostly by priming cells for LPS-induced transcription diolabeled ligand was only inhibited by IL-12 and not
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by other cytokines. The kinetics of [125I]IL-12 binding to of the known members of the NF-kB family, is involved
in the development and differentiation of DC (Burkly etDC was rapid at room temperature, reaching equilibrium
within 60 min (Figure 2A). Analysis of steady-state bind- al., 1995), and nuclear localization of RelB is associated
with effective APC function (Pettit et al., 1997); (3) twoing data by the method of Scatchard (Figure 2B) identi-
fied a single binding site with an apparent equilibrium NF-kB proteins, NF-kB1 and RelA, control the induction
of the TNFa promoter in a murine DC line (Prieschl etdissociation constant of 325 pM and 155 sites/cell. The
equilibrium dissociation constant for competing unla- al., 1996) and, in general, NF-kB factors appear to play
an important role in the activation of cytokine promotersbeled IL-12 was 240 pM with 130 sites/cell. Parallel ex-
periments of [125I]IL-12 binding to Con A lymphoblasts in DC (Baeuerle and Henkel, 1994). Using probes from
authenticNF-kB sitesor the IL-12 p40 promoter in EMSAgave results (i.e., occurrence of high- and low-affinity
binding sites) consistent with previous data in the litera- analysis, we found that IL-12 treatment of DC resulted
in the appearance of NF-kB nuclear complexes in ature (Presky et al., 1996; Wu et al., 1997).
Because Con A±activated splenocytes are known to fashion similar to that observed with a combination of
PMA and ionomycin (Figure 5). The presence of specificexpress both the b1 and b2 subunits of the IL-12R, we
comparatively analyzed these cells with fresh DC and competitors removed most or all of the nuclear com-
plexes binding to NF-kB in both fresh DC and CB1 cellsthe CB1 line in RT-PCR and RNase protection assays
for receptor subunit expression. Using RT-PCR, we treated with IL-12. These findings demonstrated that IL-
12 induces or strongly enhances activation of NF-kB infound that Con A lymphoblasts expressed b1 and b2
transcripts in contrast to the murine B lymphoma A20 fresh DC and the DC line, but no such effects were
observed with spleen cells, whether or not activatedcell line. Both DC and CB1 cells clearly expressed b2-
specific transcripts by RT-PCR and RNase protection by Con A. Subsequent experiments, using antisera to
various NF-kBfamily members, showed that the p50 andanalysis (Figure 3). However, DC and CB1 cells appeared
to express a different b1 isoform relative to Con A blasts. the RelB components of the NF-kB family bind authentic
NF-kB sites and the p40 promoter NF-kB half-site in DCSystematic RT-PCR analysis with b1 primers bridging
different regions of the mRNA combined with sequenc- (Figure 6A; data not shown). Nuclear uptake of NF-kB
p50 and RelB in IL-12-treated CB1 cells could also being of PCR products has so far revealed identity up to
at least nucleotide 1865, belonging in the intracellular demonstrated directly by immunofluorescence staining
(Figures 6B and 6C; data not shown).box 1 motif. In contrast, the use of a b1 antisense primer
complementary to nucleotides 2220±2239 resulted in Apart from the involvement of an NF-kB half-site in
the regulation of IL-12 p40 expression (Murphy et al.,no mRNA amplification (Figure 3A). Recently, several
classes of IL-12Rb1 cDNA clones have been found to 1995), members of the NF-kB family are strongly impli-
cated in the control of basal and induced MHC class Iresult from alternate splicings by comparison to the ge-
nomic sequence (Showe and Trinchieri, 1995). We are gene expression (Ting and Baldwin, 1993), and NF-kB
binding sites may be involved in I-A (Benoist and Mathis,currently attempting the production of a specific anti-
murine IL-12R b1 chain antibody that may enable us to 1990) and I-E (Baeuerle and Henkel, 1994) gene regula-
tion. It has been recently shown that inflammatory stim-perform Western blot and immunoprecipitation experi-
ments. uli such as TNFa, IL-1, and LPS (all of which can activate
NF-kB [Baeuerle and Henkel, 1994]) induce accumula-In T cells, IL-12 selectively induces nuclear DNA-bind-
ing complexes that contain Stat3 and Stat4, recently tion of MHC class II complexes on DC (Cella et al., 1997).
Because indirect evidence in our previous experimenta-cloned members of the STAT family (Jacobson et al.,
1995; Szabo et al., 1997). As a first approach to the tion had suggested that IL-12 may increase the number
and/or stability of MHC class II/P815AB complexes onidentification of the early events in IL-12 signaling in DC,
we investigated the possible induction of STAT factors DC (Grohmann et al., 1997, 1998), we became interested
in examining class II antigen expression in fresh DCcapable of binding DNA in nuclear extracts of DC and
CB1 cells exposed to IL-12 for 15 min. Using EMSA treated with IL-12. In several independent experiments,
we obtained consistent evidence for increased I-Ad ex-analysis and the FcgRI probe from the IFNg response
region of the high-affinity FcgR promoter, we failed to pression following exposure of DC to IL-12 for 18 hr.
IFNg is one of the most potent class II MHC inducersdetect nuclear complexes binding to the probe, in con-
trast to that observed with Con A blasts, in which IL- (Moses et al., 1992). TNFa, TGFb, and IFNa and -b,
which are activators of protein kinase C and cAMP, are12 clearly induced Stat4 homodimers and Stat3/Stat4
heterodimers (Figure 4). In experiments not reported other modulators of class II MHC genes, although their
role varies with experimental conditions (Ting and Bald-here using Western blot and RT-PCR analysis, we found
that DC and CB1 cells express Stat3 but not Stat4. win, 1993). Modulation of the I-A gene by TNFa is medi-
ated through an NF-kB site (Freund et al., 1990). OurAlthough these results might indicate inability of the IL-
12Rb2 subunit to transduce activating signals in DC, we present finding of no detectable IFNg in culture superna-
tants of DC exposed to IL-12 tends to exclude a majorexplored the possibility that the early events of IL-12
signaling in DC may be different from those in T cells. involvement of the former cytokine in the increased class
II molecule expression. However, whether other cyto-Several considerations led us to examine the possibil-
ity that NF-kB might be involved in IL-12 signaling in kines participate in the inducible class II gene expres-
sion resulting from DC exposure to IL-12 remains toDC. (1) NF-kB is involved in the induction of several
proinflammatory cytokines (Baeuerle and Henkel, 1994), be clarified. As regards the possible role of TNFa as a
mediator of IL-12 effects, we have found that IL-12 doesand regulation of IL-12 p40 expression occurs through
an NF-kB half-site (Murphy et al., 1995); (2) RelB, one not induce TNFa message expression by RT-PCR in DC,
IL-12 Receptor and Signaling in Dendritic Cells
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Cell Linesas opposed to the strong induction observed with IFNg,
The immortalized dendritic cell line CB1 (Paglia et al., 1993) was aand in fact the crucial promoter element for TNFa induc-
generous gift of Dr. P. Ricciardi-Castagnoli, CNR Center of Cyto-tion in DC is controlled by the NF-kB protein p65 (RelA) pharmacology, University of Milan, Milan. The murine B cell lym-
(Prieschl et al., 1996), which does not appear to be acti- phoma A20 was from the American Type Culture Collection (ATCC),
vated by IL-12 (Figure 6). Therefore, it would appear that Rockville, MD.
neither IFNg nor TNFa plays a major role in the induction
Cytokines and Antibodiesor accumulation of MHC class II complexes on DC by
Murine rIL-12 was a generous gift from Dr. B. Hubbard (GeneticsIL-12.
Institute, Inc., Cambridge, MA). IL-12 was 98.8% pure, as assessedIn monocytic cells, IFNg enhances IL-12 production
by SDS-PAGE, and endotoxin contamination was ,0.9 EU/mg on
mostly by priming cells for LPS-induced transcription Limulus amoebocyte assay. The specific activity of the purified rIL-
of the p40 gene (Ma et al., 1996), and the induction 12 preparation, measured as ability to stimulate proliferation in hu-
of IFNg by IL-12 acts in a positive feedback loop that man phytohemoagglutinin-activated blasts, was 3.1 3 106 U/mg.
Endotoxin was removed from all solutions containing IL-12 withrepresents an important amplifying mechanism in the
Detoxi-gel (Pierce Chemical Co., Rockford, IL), resulting in endo-inflammatory response to infection (Romani et al., 1997).
toxin contamination below the detection limit (0.05 EU/ml) of theThe finding of an IL-12R in DC capable of activating
assay (Coatest Endotoxin, Chromogenix AB, MoÈ lndal, Sweden). Mu-
transcription factors for the p40 promoter NF-kB half- rine rIFNg was from Genzyme Corp. (Boston, MA).
site prompted us to investigate the possibility that IL-12 Affinity purified anti-CD11c (N418, rat IgG2a), anti-I-Ad (MK-D6,
mouse IgG2a), and anti-mouse DC (33D1, rat IgG2b) MAbs weremight be involved in the regulation of its own production.
obtained from ATCC. Rat anti-mouse IL-12 p40 MAb C17.8 andWe comparatively analyzed IL-12 and IFNg for ability to
hamster anti-mouse IL-12 p35 (clone Red-T) were from Genzymeprime DC for LPS-induced production of IL-12 p70. In
Corp. N418, MK-D6, 33D1, and C17.8 MAbs were conjugated to
fact, murine splenic DC are known to express low levels FITC or biotinusing conventional methods. FITC-labeled anti-mouse
of LPS receptor CD14 under resting conditions (Kato et B7-1 and B7-2 and anti-mouse CD3 (145-2C11) were from Phar-
al., 1997). We obtained evidence that LPS alone or a mingen. PE-labeled anti-mouse B220 was a gift from Dr. L. D'Adamio
(NIH, Bethesda, MD).combination of LPS and IFNg induced only a limited
production of p70 (Figure 7). A greater effect was ob-
Dendritic Cell Preparationserved with IL-12 alone. However, the combination of
DC were prepared from collagenase-treated spleens (collagenaseIL-12 and LPS resulted in the production of very high
type IV, Sigma Chemical Co., St. Louis, MO), as described (Steinman
levels of IL-12 p70. The failure of IFNg plus LPS to induce et al., 1986). In brief, total spleen cells were suspended in dense
high levels of IL-12 in DC is in line with recent observa- BSA (p 5 1.080), overlaid with 1 ml of RPMImedium, and centrifuged
in a swingout bucket rotor at 7,500 rpm for 20 min at 48C. The low-tions by others (Kato et al., 1997). This may beconsistent
density fraction at the interface was collected and washed severalwith the notion that the various APC serve very different
times. The recovered cells were resuspended in RPMI medium sup-immune functions and that DC may be unique in their
plemented with 10% FCS and allowed to adhere for 2 hr, and this
ontogenetic and functional characteristics (Peters et al., was followed by an additional 18 hr incubation to allow DCto detach.
1996). It would be tempting to speculate that IL-12 con- Contaminating B cells were further removed by one round of panning
tributes to effective APC function in DC by activating on polyvalent goat anti-mouse Ig (Sigma Chemical Co.). The recov-
ered cells were routinely .96% N4181. Cytofluorimetric analysis ofNF-kB, increasing class II antigen expression, and regu-
these cells with several MAbs revealed a characteristic DC pheno-lating the production of IL-12.
type (Figure 1). In addition, no detectable IFNg was present in cultureIn conclusion, we have shown that DC expressa single
supernatants from IL-12-treated DC, thus excluding a significant
class of high-affinity IL-12R on their surface. We have contamination by NK cells. In selected experiments, DC were puri-
provided evidence that IL-12 binding on DC transduces fied from collagenase-treated spleens using a positive selection
column and CD11c MicroBeads (Miltenyi Biotec GmbH, Bergischactivating signals via nuclear localization of p50 and
Gladbach, Germany). The two purification procedures led to compa-RelB, two members of the NF-kB family. This unique
rable results when cells were assayed in parallel in in vivo and infeature of IL-12 effects on DC may confer unique actions
vitro experiments.
on the target cells, including increased class II antigen
expression and enhanced production of endogenous Binding Assays
IL-12. Therefore, our present data demonstrate a novel Purified rIL-12 was labeled with 125I by a modification of the IodoGen
possible cellular target for IL-12, suggest the existence method (Pierce Chemical Co., Rockford, IL) as previously described
(Chizzonite et al., 1992; Wu et al., 1997). Activation of splenocytesof IL-12 receptors structurally and functionally distinct
with Con A (Presky et al., 1996) and [125I]IL-12 binding assays (Wufrom those in T and NK cells, and demonstrate the
et al., 1997) was performed as previously reported. All bindinginvolvement of members of the NF-kB family in IL-12
assays were performed in duplicate (DC) or triplicate (Con A blasts)
signal transduction. Because until now DC have only using 5 x 106 DC and 3 3 106 Con A blasts in a volume of 100 ml.
been thought to make rather than respond to IL-12, our Receptor binding data were analyzed using the LIGAND nonlinear
regression program (Munson, 1983) and plotted by the method ofpresent finding of a functional high-affinity IL-12R on
Scatchard (1949).DC may have a number of important implications in the
general pathways of immunoregulation.
RNA Preparation and PCR
These procedures were previously described in detail (Grohmann
et al., 1995b; Bianchi et al., 1996). b-actin primers were purchased
Experimental Procedures from Clontech Laboratories (Palo Alto, CA), and IL-12R primers were
synthesized according to published sequences (Chua et al., 1995;
Mice Presky et al., 1996). The sequence of 59 sense primer and 39 anti-
DBA/2J (H-2d) were obtained from Charles River Breeding Labora- sense primer of IL-12Rb1 and IL-12Rb2 were as follows:
tories (Calco, Milan, Italy). Male mice were used at the age of 2 to
4 months. 59 IL-12Rb1 [239±259], TAT-GAG-TGC-TCC-TGG-CAG-TAT;
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39 IL-12Rb1 [787±807], GGC-ATG-CTC-CAA-TCA-CTC-CAG; FCS and LPS (1 mg/ml). Supernatants were collected at 1 and 24
hr prior to assaying IL-12 p70 contents by ELISA using the hamster59 IL-12Rb1 [1073±1092], AAT-GTG-CTC-GCC-AAA-ACT-CG;
39 IL-12Rb1 [2220±2239], CGC-AGT-CTT-ATG-GGT-CCT-CC; anti-mouse p35 MAb and biotinylated anti-mouse p40 (C17.8) MAb.
The sensitivity limit of this assay was approximately 100 pg/ml for59 IL-12Rb2 [1760±1779], ACA-TTA-CTG-CCA-TCA-CAG-AG; and
39 IL-12Rb2 [2242±2261], AGG-AGA-TTA-TCC-GTA-GGT-AG. IL-12 p70.
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